Lifevantage Corp (LFVN) stock
LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 16/3023% below fair value
$4.97−0.07 (-1.39%)
Close on Nov 13, 2026Market cap $62.26MP/E 23.7Yield 3.72%
Earnings
Lifevantage's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 3, 2027
Q2 FY2027 · estimated, after the close
Revenue, Q1 FY2027
$37.10M
-22.1% on a year earlier
Adjusted earnings per diluted share, Q1 FY2027
$0.05
$0.18 a year earlier
Latest guidance
Lowered
May 6, 2026 · 1 item
Quarterly results
Revenue and earnings per share from each of Lifevantage's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q2 FY2027ended Dec 31, 2026 | Feb 3, 2027Expected | – | – | – | – | – |
| Q1 FY2027ended Sep 30, 2026 | Nov 9, 2026after the close | $37.10M | -22.1% | -$0.02 | $0.05 | Release |
| Q4 FY2026ended Jun 30, 2026 | Aug 27, 2026after the close | $42.40M | -23.0% | $0.10 | $0.11 | Release |
| Q3 FY2026ended Mar 31, 2026 | May 6, 2026after the close | $43.70M | -25.2% | $0.11 | $0.12 | Release |
| Q2 FY2026ended Dec 31, 2025 | Feb 4, 2026after the close | $48.90M | -27.9% | $0.02 | $0.15 | Release |
| Q1 FY2026ended Sep 30, 2025 | Nov 4, 2025after the close | $47.60M | +0.8% | $0.17 | $0.18 | Release |
| Q4 FY2025ended Jun 30, 2025 | Sep 4, 2025after the close | $55.10M | +12.7% | $0.15 | $0.17 | Release |
| Q3 FY2025ended Mar 31, 2025 | May 6, 2025after the close | $58.40M | +21.2% | $0.26 | $0.26 | Release |
| Q2 FY2025ended Dec 31, 2024 | Feb 5, 2025after the close | $67.80M | +31.4% | $0.19 | $0.22 | Release |
| Q1 FY2025ended Sep 30, 2024 | Oct 29, 2024after the close | $47.20M | -8.2% | $0.14 | $0.15 | Release |
| Q4 FY2024ended Jun 30, 2024 | Aug 28, 2024after the close | $48.90M | -9.8% | $0.10 | $0.14 | Release |
| Q3 FY2024ended Mar 31, 2024 | May 2, 2024after the close | $48.20M | -10.2% | $0.13 | $0.21 | Release |
| Q2 FY2024ended Dec 31, 2023 | Jan 30, 2024after the close | $51.60M | -3.9% | -$0.05 | $0.10 | Release |
| Q1 FY2024ended Sep 30, 2023 | Nov 9, 2023after the close | $51.40M | -0.8% | $0.05 | $0.13 | Release |
| Q4 FY2023ended Jun 30, 2023 | Aug 28, 2023after the close | $54.20M | +6.5% | $0.15 | $0.17 | Release |
| Q3 FY2023ended Mar 31, 2023 | May 4, 2023after the close | $53.70M | +7.4% | $0.08 | $0.08 | Release |
| Q2 FY2023ended Dec 31, 2022 | Feb 2, 2023after the close | $53.70M | +2.9% | -$0.08 | -$0.07 | Release |
| Q1 FY2023ended Sep 30, 2022 | Nov 2, 2022after the close | $51.80M | -2.6% | $0.05 | $0.06 | Release |
| Q4 FY2022ended Jun 30, 2022 | Aug 23, 2022after the close | $50.90M | – | -$0.11 | $0.01 | Release |
| Q3 FY2022ended Mar 31, 2022 | May 3, 2022after the close | $50.00M | – | $0.09 | $0.12 | Release |
| Q2 FY2022ended Dec 31, 2021 | Feb 1, 2022after the close | $52.20M | – | $0.01 | $0.05 | Release |
| Q1 FY2022ended Sep 30, 2021 | Nov 4, 2021after the close | $53.20M | – | $0.25 | $0.23 | Release |
| Q4 FY2021ended Jun 30, 2021 | Aug 19, 2021after the close | – | – | – | – | Filing |
| Q3 FY2021ended Mar 31, 2021 | Apr 29, 2021after the close | – | – | – | – | Filing |
| Q2 FY2021ended Dec 31, 2020 | Feb 2, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Sep 30, 2020 | Nov 3, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period Lifevantage guided for has been reported
Guidance vs results
The last range Lifevantage gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | adjusted earnings per share | $0.60 – $0.80 | $0.56Σ4Q | Below range |
| FY2026 | Revenue | $185.00M – $200.00M | $182.60MΣ4Q | Below range |
| FY2025 | adjusted earnings per share | $0.72 – $0.88 | $0.80Σ4Q | Within range |
| FY2025 | Revenue | $228.00M – $235.00M | $228.50MΣ4Q | Within range |
Guidance history
Every forecast Lifevantage put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| May 6, 2026 | full year tax rate | FY2026 | 18% – 20% | Lowered |
| Feb 4, 2026 | adjusted EBITDA | FY2026 | $15.00M – $19.00M | Lowered |
| Feb 4, 2026 | adjusted earnings per share | FY2026 | $0.60 – $0.80 | Lowered |
| Feb 4, 2026 | full year tax rate | FY2026 | 22% – 24% | Lowered |
| Feb 4, 2026 | revenue | FY2026 | $185.00M – $200.00M | Lowered |
| Nov 4, 2025 | adjusted EBITDA | FY2026 | $23.00M – $26.00M | Reaffirmed |
| Nov 4, 2025 | adjusted earnings per share | FY2026 | $1.00 – $1.15 | Reaffirmed |
| Nov 4, 2025 | tax rate | FY2026 | 24% – 26% | Reaffirmed |
| Nov 4, 2025 | revenue | FY2026 | $225.00M – $240.00M | Reaffirmed |
| Sep 4, 2025 | adjusted EBITDA | FY2026 | $23.00M – $26.00M | New |
| Sep 4, 2025 | adjusted earnings per share | FY2026 | $1.00 – $1.15 | New |
| Sep 4, 2025 | full year tax rate | FY2026 | 24% – 26% | New |
| Sep 4, 2025 | revenue | FY2026 | $225.00M – $240.00M | New |
| May 6, 2025 | adjusted EBITDA | FY2025 | $21.00M – $24.00M | New |
| May 6, 2025 | adjusted earnings per share | FY2025 | $0.72 – $0.88 | New |
| May 6, 2025 | full year tax rate | FY2025 | 22% – 24% | New |
| May 6, 2025 | revenue | FY2025 | $228.00M – $235.00M | New |
| Feb 5, 2025 | adjusted EBITDA | FY2025 | $21.00M – $24.00M | Raised |
| Feb 5, 2025 | adjusted earnings per share | FY2025 | $0.72 – $0.88 | Raised |
| Feb 5, 2025 | full year tax rate | FY2025 | 22% – 24% | Lowered |
| Feb 5, 2025 | revenue | FY2025 | $235.00M – $245.00M | Raised |
| Oct 29, 2024 | adjusted EBITDA | FY2025 | $18.00M – $21.00M | Reaffirmed |
| Oct 29, 2024 | adjusted earnings per share | FY2025 | $0.70 – $0.80 | Reaffirmed |
| Oct 29, 2024 | full year tax rate | FY2025 | 25% – 27% | Reaffirmed |
| Oct 29, 2024 | revenue | FY2025 | $200.00M – $210.00M | Reaffirmed |
| Aug 28, 2024 | adjusted EBITDA | FY2025 | $18.00M – $21.00M | New |
| Aug 28, 2024 | adjusted earnings per share | FY2025 | $0.70 – $0.80 | New |
| Aug 28, 2024 | tax rate | FY2025 | 25% – 27% | New |
| Aug 28, 2024 | revenue | FY2025 | $200.00M – $210.00M | New |
| May 2, 2024 | adjusted EBITDA | FY2024 | $16.00M – $18.00M | Reaffirmed |
| May 2, 2024 | adjusted earnings per share | FY2024 | $0.57 – $0.67 | Reaffirmed |
| May 2, 2024 | full year tax rate | FY2024 | 22% – 24% | Reaffirmed |
| May 2, 2024 | revenue | FY2024 | $202.00M – $205.00M | New |
| Jan 30, 2024 | adjusted EBITDA | FY2024 | $16.00M – $18.00M | Reaffirmed |
| Jan 30, 2024 | adjusted earnings per share | FY2024 | $0.57 – $0.67 | Raised |
| Jan 30, 2024 | tax rate | FY2024 | 22% – 24% | Lowered |
| Jan 30, 2024 | revenue | FY2024 | $207.00M – $213.00M | Lowered |
| Nov 9, 2023 | adjusted EBITDA | FY2024 | $16.00M – $18.00M | Reaffirmed |
| Nov 9, 2023 | adjusted earnings per share | FY2024 | $0.52 – $0.62 | Reaffirmed |
| Nov 9, 2023 | tax rate | FY2024 | 22% – 25% | New |
| Nov 9, 2023 | revenue | FY2024 | $216.00M – $226.00M | Reaffirmed |
| Aug 28, 2023 | adjusted EBITDA | FY2024 | $16.00M – $18.00M | New |
| Aug 28, 2023 | adjusted earnings per share | FY2024 | $0.52 – $0.62 | New |
| Aug 28, 2023 | revenue | FY2024 | $216.00M – $226.00M | New |
| May 4, 2023 | adjusted EBITDA | FY2023 | $11.00M – $13.00M | Reaffirmed |
| May 4, 2023 | adjusted earnings per share | FY2023 | $0.20 – $0.26 | Lowered |
| May 4, 2023 | revenue | FY2023 | $209.00M – $212.00M | Raised |
| Feb 2, 2023 | adjusted EBITDA | FY2023 | $11.00M – $13.00M | Lowered |
| Feb 2, 2023 | adjusted earnings per share | FY2023 | $0.22 – $0.28 | Lowered |
| Feb 2, 2023 | full year tax rate | FY2023 | 31% | New |
| Feb 2, 2023 | revenue | FY2023 | $202.00M – $212.00M | Raised |
| Nov 2, 2022 | adjusted EBITDA | FY2023 | $12.00M – $14.00M | Reaffirmed |
| Nov 2, 2022 | adjusted earnings per share | FY2023 | $0.27 – $0.39 | Reaffirmed |
| Nov 2, 2022 | revenue | FY2023 | $200.00M – $212.00M | New |
| Aug 23, 2022 | adjusted EBITDA | FY2023 | $12.00M – $14.00M | New |
| Aug 23, 2022 | adjusted earnings per share | FY2023 | $0.27 – $0.39 | New |
| Aug 23, 2022 | revenue | FY2023 | $200.00M – $212.00M | New |
| May 3, 2022 | Adjusted EBITDA | FY2022 | $15.00M | Lowered |
| May 3, 2022 | Adjusted earnings per share | FY2022 | $0.52 – $0.56 | Lowered |
| May 3, 2022 | Revenue | FY2022 | $204.00M – $207.00M | Lowered |
| Feb 1, 2022 | Adjusted EBITDA | FY2022 | $18.00M – $20.00M | Lowered |
| Feb 1, 2022 | Adjusted earnings per share | FY2022 | $0.67 – $0.71 | Lowered |
| Feb 1, 2022 | Revenues | FY2022 | $212.00M – $220.00M | New |
| Nov 4, 2021 | adjusted EBITDA | FY2022 | $22.00M – $24.00M | New |
| Nov 4, 2021 | adjusted earnings per share | FY2022 | $0.83 – $0.87 | New |
| Nov 4, 2021 | revenue | FY2022 | $225.00M – $235.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Lifevantage filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- News
See a number that looks wrong?